Insulin sensitivity pilot study (Ruggenenti): A pilot study in nondiabetic subjects at increased cardiovascular risk with insulin resistance found that 2 g/day of oral ALCAR for 6 months improved insulin-mediated glucose disposal (measured by euglycemic hyperinsulinemic clamp) alongside reductions in blood pressure [5][21]
This may make it more effective in supporting long-term weight loss and metabolic health
Every injection is administered by licensed clinicians in a professional environment focused on comfort and safety
As far as hormone therapy is concerned, non-oral options include transdermal methods which are absorbed through the skin, like gels or patches, and vaginal methods like rings, creams and inserts
Keep out of reach of children.*These statements have not been evaluated by the Food and Drug Administration
It is cold, requires zero cooking, and digests smoothly